Bailard Inc. Makes New $442,000 Investment in Enhabit, Inc. $EHAB

Bailard Inc. bought a new stake in shares of Enhabit, Inc. (NYSE:EHAB) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 55,200 shares of the company’s stock, valued at approximately $442,000. Bailard Inc. owned about 0.11% of Enhabit at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. AQR Capital Management LLC grew its position in Enhabit by 115.6% during the first quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock valued at $1,867,000 after buying an additional 115,456 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Enhabit by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock worth $262,000 after acquiring an additional 1,248 shares during the period. Jones Financial Companies Lllp boosted its stake in Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after acquiring an additional 8,879 shares during the last quarter. Empowered Funds LLC grew its position in shares of Enhabit by 8.4% during the 1st quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock valued at $1,675,000 after acquiring an additional 14,690 shares during the period. Finally, Acadian Asset Management LLC purchased a new stake in shares of Enhabit during the 1st quarter worth approximately $114,000.

Enhabit Stock Performance

NYSE:EHAB opened at $10.82 on Friday. The business’s fifty day moving average is $9.54 and its 200 day moving average is $8.37. The firm has a market cap of $547.50 million, a price-to-earnings ratio of -43.27 and a beta of 1.66. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58. Enhabit, Inc. has a 52-week low of $6.47 and a 52-week high of $11.35.

Enhabit (NYSE:EHAB) last posted its earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The business had revenue of $263.60 million during the quarter, compared to analyst estimates of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current year.

Analyst Ratings Changes

Several research firms recently commented on EHAB. TD Cowen upgraded Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Oppenheimer upgraded Enhabit from a “market perform” rating to an “outperform” rating and set a $14.00 target price on the stock in a research note on Thursday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Wolfe Research set a $12.00 price objective on Enhabit in a report on Thursday, January 8th. Finally, Citigroup restated a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $12.10.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.